Novonix Days Sales Outstanding from 2010 to 2024

NVX Stock  USD 2.69  0.76  39.38%   
Novonix Days Sales Outstanding yearly trend continues to be fairly stable with very little volatility. Days Sales Outstanding is likely to outpace its year average in 2024. During the period from 2010 to 2024, Novonix Days Sales Outstanding regression line of annual values had r-squared of  0.69 and arithmetic mean of  554.36. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
161.33718022
Current Value
270.5
Quarterly Volatility
445.85551366
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5 M, Interest Expense of 3 M or Selling General Administrative of 47.1 M, as well as many indicators such as Price To Sales Ratio of 28.8, Dividend Yield of 0.0167 or PTB Ratio of 2.05. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
  
Check out the analysis of Novonix Correlation against competitors.

Latest Novonix's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Novonix Ltd ADR over the last few years. It is Novonix's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novonix's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Novonix Days Sales Outstanding Regression Statistics

Arithmetic Mean554.36
Geometric Mean359.14
Coefficient Of Variation80.43
Mean Deviation428.00
Median270.50
Standard Deviation445.86
Sample Variance198,787
Range919
R-Value(0.83)
Mean Square Error66,189
R-Squared0.69
Significance0.0001
Slope(82.86)
Total Sum of Squares2.8M

Novonix Days Sales Outstanding History

2024 270.5
2023 161.34
2022 192.29
2021 146.72
2020 142.65
2019 105.36
2018 111.87

About Novonix Financial Statements

Novonix investors use historical fundamental indicators, such as Novonix's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novonix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Sales Outstanding 161.34  270.50 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.